SCHEMBL9057774

SCHEMBL9057774

COc1ccc2[c]c(-c3ccccc3OC)ccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.47
CYP2A6 P11509 2/20 0.47
CYP1A1 P04798 3/20 0.42
CYP1B1 Q16678 3/20 0.42
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HPGD P15428 1/20 0.42
HDAC4 P56524 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
AR P10275 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
PTGS2 P35354 1/20 0.39
MAPK1 P28482 1/20 0.38
RECQL P46063 1/20 0.38
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8734461 0.86 CYP1A2 (0.39) CYP1A2CYP2A6CYP1A1CYP1B1ALDH1A1
SCHEMBL27802213 0.84 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2HPGDKDM4ERAB9A
SCHEMBL27802200 0.84 NPC1 (0.40) CYP2A6ALDH1A1SMN1; SMN2HPGDL3MBTL1
SCHEMBL8732812 0.84 CYP1A2 (0.37) CYP1A2CYP2A6CYP1A1CYP1B1ALDH1A1
SCHEMBL3241635 0.83 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2HPGDL3MBTL1KDM4E
SCHEMBL6698059 0.82 CYP1A1 (0.47) CYP1A2CYP2A6CYP1A1CYP1B1ALDH1A1
SCHEMBL11723042 0.82 CYP2A6 (0.52) CYP1A2CYP2A6KDM4ENPC1RAB9A
SCHEMBL9054823 0.80 CYP1A2 (0.52) CYP1A2CYP2A6ALDH1A1SMN1; SMN2HPGD
SCHEMBL7735652 0.76 HSD17B1 (0.49) CYP1A2CYP2A6KDM4ENPC1RAB9A
SCHEMBL7937480 0.76 CYP1A2 (0.46) CYP1A2CYP2A6CYP1A1CYP1B1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996009051-A1 A METHOD FOR MINIMIZING THE UTEROTROPHIC EFFECT OF TAMOXIFEN AND TAMOXIFEN ANALOGS ELI LILLY AND COMPANY (US) 1996-03-28 WO disclosed